The three germline BRCA1/2 variants missed using our in-house tumour BRCA1/2 assay included BRCA1 Exon 13 duplication, BRCA2 Exon 1–2 deletion and BRCA2 Exon 14–16 deletion. This evidence concerns the gene BRCA1 and neoplasm.